• Latest Posts

Dupixent gets EU nod for children with severe atopic dermatitis

Positive Dupixent eosinophilic esophagitis phase 3 results

European Commission approves Dupixent as first and only targeted prurigo nodularis medicine

Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2

Prurigo nodularis treatment recommended for EU approval  


Late-breaking data shows significant remission in children with EoE

Treatment for adults with chronic skin condition approved by FDA

Regeneron and Sanofi announce published trial results in children with dermatitis

Improved vision with less eye injections for patients after primary endpoints met in trials

OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer